Amarin Corp PLC(AMRN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

AMRN Amarin Corp PLC

Market Closed 12-12 16:00:00 EST

14.36

-0.12

-0.83%

盘后14.36

+0.000.00%

17:04 EST

High14.62	Low14.00	Vol78.97K
Open14.49	D1 Closing14.48	Amplitude4.32%
Mkt Cap298.58M	Tradable Cap269.34M	Total Shares20.79M
T/O1.13M	T/O Rate0.42%	Tradable Shares18.76M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"AMRN","market":"US","secType":"STK","nameCN":"Amarin Corp PLC","latestPrice":14.36,"timestamp":1765573200000,"preClose":14.48,"halted":0,"volume":78974,"hourTrading":{"tag":"盘后","latestPrice":14.36,"preClose":14.36,"latestTime":"17:04 EST","volume":5,"amount":71.81,"timestamp":1765577065814},"delay":0,"floatShares":18756131,"shares":20792684,"eps":-4.187461,"marketStatus":"Market Closed","change":-0.12,"latestTime":"12-12 16:00:00 EST","open":14.49,"high":14.62,"low":13.995,"amount":1133095.5212,"amplitude":0.043163,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.187461,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":1,"adrRate":20,"listingDate":733640400000,"exchange":"NASDAQ","adjPreClose":14.48,"preHourTrading":{"tag":"盘前","latestPrice":14.65,"preClose":14.48,"latestTime":"08:42 EST","volume":300,"amount":4358.0001,"timestamp":1765546941847},"postHourTrading":{"tag":"盘后","latestPrice":14.36,"preClose":14.36,"latestTime":"17:04 EST","volume":5,"amount":71.81,"timestamp":1765577065814},"volumeRatio":0.7261012521805856,"impliedVol":0.4433,"impliedVolPercentile":0.1486},"requestUrl":"/m/hq/s/AMRN/wiki","defaultTab":"wiki","newsList":[{"id":"2590539837","title":"European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2590539837","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590539837?lang=en_us&edition=fundamental","pubTime":"2025-12-11 00:08","pubTimestamp":1765382894,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were heading higher late Wednesday morning, rising 0.67% to 1,636.27 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies DBV Technologies  and Cellectis , which climbed 14% and 6.8%, respectively. They were followed by pharmaceutical company Novo Nordisk  and brewing company Anheuser-Busch InBev , which advanced 3.8% and 1.8%, respectively.The decliners from continental Europe were led by biotech firm Evaxion  and semiconductor company Sequans Communications , which fell 3.8% and 2.1%, respectively. They were followed by internet advertising firm Criteo  and medical device maker EDAP TMS , which were down 1.9% each.From the UK and Ireland, the gainers were led by biopharmaceutical company Biodexa Pharmaceuticals  and lender HSBC , which rose 33% and 4.1%, respectively. They were followed by biopharmaceutical company Bicycle Therapeutics  and educational publish","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BUD","LU0052756011.USD","BK4141","BK4599","LU1093756325.SGD","BK7104","IE00BFMHRM44.USD","BK4585","EDAP","LU0128525689.USD","BK4207","IE00BZ1G4Q59.USD","SQNS","BK4007","AMRN","BK4204","EVAX","BK4111","AKTX","CLLS","BK4139","LU1267930227.SGD","BK4009","BK4082","BK4107","BDRX","BK4117","LU2236285917.USD","00005","CRTO","NCNA","BCYC","BK4532","BK4588","LU0154236417.USD","BK4521","DBVT","HSBC","BK4158","PSO","NVO","BK7119","TRIB","LU1093756168.USD","LU0310800965.SGD","IE00BKVL7J92.USD"],"gpt_icon":1},{"id":"2590358352","title":"European Equities Traded in the US as ADRs Little Changed in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2590358352","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590358352?lang=en_us&edition=fundamental","pubTime":"2025-12-09 00:01","pubTimestamp":1765209714,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were little changed late Monday morning, easing less than 0.1% to 1,630.2 on the S&P Europe Select ADR Index.From continental Europe,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DEO","AMRN","BK4585","LU0300736062.USD","SNY","EVAX","BK4568","MTLS","BK7511","BK4588","BK4139","AKTX","LU1093756168.USD","IE00BZ1G4Q59.USD","TRIB","LU0124676726.USD","BK4082","BK4169","SLN","BK4532","BNTX","LU0689626769.HKD","LU1093756325.SGD","BK4599","DGE.UK","BK4168","BK4551","BDRX","IE00BFXG1179.USD","LU0154236417.USD","LU0300736492.USD","IE00BKVL7J92.USD","BK4548","UL","BK4559","BK4007","BK4535","BK4023","ULVR.UK","BK7104","BK7507","BK4183","AUTL","EDAP","BK4592","UN","DBVT","BHP","BK7095","BK4546"],"gpt_icon":1},{"id":"2583205592","title":"European Equities Traded in the US as American Depositary Receipts Slightly Higher in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2583205592","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583205592?lang=en_us&edition=fundamental","pubTime":"2025-11-14 00:19","pubTimestamp":1763050780,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were slightly higher late Thursday morning, rising 0.11% to 1,641.58 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by telecommunications operator Telefonica  and oil and gas company TotalEnergies , which rose 3.9% and 2.1%, respectively. They were followed by biopharmaceutical company Grifols  and semiconductor company Sequans Communications , which gained 1.9% and 1.3% respectively.The decliners from continental Europe were led by biotech companies BioNTech  and Evaxion , which declined 6.1% and 5% respectively. They were followed by accommodations booking company trivago  and internet browser company Opera , which were down 2.8% and 2.5% respectively.From the UK and Ireland, the gainers were led by pharmaceutical company Silence Therapeutics  and biopharmaceutical company Amarin , which advanced 2.4% and 1.3% respectively. They were followed by pharmaceutical company AstraZeneca  and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4009","EVAX","SQNS","BK4201","LU1829250122.USD","BK4023","LU2237443895.HKD","LU2237443382.USD","PSO","AZN","BK4141","BK4505","BK4107","LU0109394709.USD","BK4535","MREO","TRVG","BK4588","TTE","BK4561","LU0889565916.HKD","BNTX","LU2129689605.HKD","LU2417539215.USD","LU2236285917.USD","LU0320765992.SGD","AMRN","AUTL","BK4548","LU2237443465.HKD","LU2129689431.USD","AFG","BK4585","GRFS","BK4115","WPP.AU","BK4139","WPP","BK4111","SLN","LU2237443549.SGD","LU2237443622.USD","BK4568","LU2129689514.USD","LU2456880835.USD","TEF","BDRX","BK4077","OPRA","BK4117"],"gpt_icon":0},{"id":"2582803070","title":"European Equities Traded in the US as American Depositary Receipts Start Week Trending Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2582803070","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582803070?lang=en_us&edition=fundamental","pubTime":"2025-11-11 00:05","pubTimestamp":1762790700,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts opened the week higher late Monday morning, rising 0.77% to 1,603.65 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies Cellectis  and Genfit , which climbed 12.2% and 7.2% respectively. They were followed by 3D printer company Materialise  and lender Banco Bilbao Vizcaya Argentaria , which advanced 4.8% and 2.4% respectively.The decliners from continental Europe were led by petroleum refiner Equinor  and telecommunications operator Telefonica , which fell 2.2% and 1.4% respectively. They were followed by consumer goods giant Unilever  and telecommunications company Ericsson , which were down 1% and 0.8% respectively.From the UK and Ireland, the gainers were led by alcoholic beverage company Diageo  and biotech firm Autolus Therapeutics , which rose 4.9% and 2.2% respectively. They were followed by pharmaceutical company AstraZeneca  and biopharmaceutical comp","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ERIC","AMRN","AKTX","BK4591","SLN","UN","BK4201","LU0084288595.USD","BK4007","LU0109394709.USD","LU2236285917.USD","LU2456880835.USD","UL","BK4559","BK4554","BK4207","BK4183","BBVA","BDRX","AFG","EQNR","BK4107","DAVA","GNFT","BK4117","BK4169","LU0689626769.HKD","BK4023","BK4588","LU0124676726.USD","LU0648005311.SGD","BK4515","LU0320765992.SGD","DGE.UK","DEO","TEF","BK4020","BK4592","BK4546","CLLS","AUTL","DAVA.AU","ULVR.UK","LU0889565916.HKD","LU2462157665.USD","BK4568","AZN","BK4134","MTLS","LU1829250122.USD"],"gpt_icon":0},{"id":"2582811045","title":"Amarin announces new post hoc analysis of aspirin use in REDUCE-IT","url":"https://stock-news.laohu8.com/highlight/detail?id=2582811045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582811045?lang=en_us&edition=fundamental","pubTime":"2025-11-10 08:10","pubTimestamp":1762733410,"startTime":"0","endTime":"0","summary":"Amarin (AMRN) highlighted a new post hoc analysis of aspirin use in REDUCE-IT reinforcing that icosapent ethyl significantly reduced cardiovascular...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/amarin-announces-new-post-hoc-analysis-of-aspirin-use-in-reduce-it-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/amarin-announces-new-post-hoc-analysis-of-aspirin-use-in-reduce-it-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMRN","BK4139"],"gpt_icon":0},{"id":"2582289816","title":"New REDUCE-IT® Aspirin Analysis Presented at AHA Scientific Sessions 2025 Reinforces VASCEPA®/VAZKEPA® (Icosapent Ethyl) Reduced Cardiovascular Events in High-Risk Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2582289816","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582289816?lang=en_us&edition=fundamental","pubTime":"2025-11-10 05:15","pubTimestamp":1762722900,"startTime":"0","endTime":"0","summary":"DUBLIN and BRIDGEWATER, N.J., Nov.  09, 2025  (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company committed to advancing the science of cardiovascular care, today highlighted a newpos","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/09/3184162/18362/en/New-REDUCE-IT-Aspirin-Analysis-Presented-at-AHA-Scientific-Sessions-2025-Reinforces-VASCEPA-VAZKEPA-Icosapent-Ethyl-Reduced-Cardiovascular-Events-in-High-Risk-Patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPE","TG","BK4082","CSII","BK4110","BK4090","CV","AMRN","BK4161","BK4139","ARR","BK4153","BK4604"],"gpt_icon":1},{"id":"2581401859","title":"European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2581401859","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581401859?lang=en_us&edition=fundamental","pubTime":"2025-11-07 00:19","pubTimestamp":1762445945,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were lower late Thursday morning, declining 0.1% to 1,589.29 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biotech firm Evaxion  and biopharmaceutical company DBV Technologies , which rose 5.7% and 4.6% respectively. They were followed by lender Banco Bilbao Vizcaya Argentaria  and biopharmaceutical company argenx , which were up 2.9% and 2.7% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications  and software firm SAP , which dropped 3.5% and 3.3% respectively. They were followed by internet browser company Opera  and biopharmaceutical company Grifols , which lost 3% and 2.7% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Bicycle Therapeutics  and pharmaceutical company AstraZeneca , which advanced 4.4% and 3.3% respectively. They were followed by biopharmaceutical company Amarin  and pha","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1839390173.USD","SLN","BK4535","OPRA","SG9999002620.SGD","BBVA","SAP","DBVT","SG9999014492.USD","BK4548","BCYC","IE00BJJMRZ35.SGD","BK4568","LU0532188223.SGD","LU1048588211.SGD","PSO","BK4207","TRIB","BK4117","LU0499858602.USD","LU0072462343.USD","IE0002141913.USD","LU2045819591.USD","SG9999005177.SGD","SNN","SQNS","ARGX","IE00BJT1NW94.SGD","LU0589944569.HKD","LU2360107671.USD","BK4111","BK4528","LU1770036033.HKD","LU2065170008.USD","DEO","AFG","SG9999006266.SGD","LU1242518931.SGD","LU0251143029.SGD","DGE.UK","LU1861220207.SGD","LU0979878070.USD","BK4007","EVAX","AMRN","BK4505","GRFS","LU0175139822.USD","AZN"],"gpt_icon":1},{"id":"2580215264","title":"Amarin Unveils New REDUCE-IT Analyses Highlighting VASCEPA Efficacy at AHA 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2580215264","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580215264?lang=en_us&edition=fundamental","pubTime":"2025-11-03 21:30","pubTimestamp":1762176623,"startTime":"0","endTime":"0","summary":"Amarin Corporation plc announced it will present new analyses at the American Heart Association's Scientific Sessions 2025, scheduled for November 7-10 in New Orleans, Louisiana. The presentations will include new data from the REDUCE-IT study, evaluating the efficacy of Icosapent Ethyl  for cardiovascular risk reduction, including outcomes based on baseline aspirin use. Additional mechanistic studies will address the anti-oxidant, anti-inflammatory, and endothelial-protective properties of Eicosapentaenoic Acid , particularly its effects on lipoprotein oxidation and endothelial cell stress responses. The results are scheduled to be presented during designated abstract and poster sessions at the upcoming conference.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nNDL2fXkjK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","LU2095319765.USD","NDAQ","LU0314104364.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BK4112","BK4585","AMRN","IE00BKPKM429.USD","BK4588","IE00BGHQF748.EUR","BK4139","LU2210149790.SGD"],"gpt_icon":0},{"id":"2580169504","title":"Amarin Corporation plc Files Initial Statement of Beneficial Ownership for EVP and Chief Operating Officer David Paul Keenan","url":"https://stock-news.laohu8.com/highlight/detail?id=2580169504","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580169504?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:30","pubTimestamp":1761942648,"startTime":"0","endTime":"0","summary":"Amarin Corporation plc has filed an initial statement of beneficial ownership  with the U.S. Securities and Exchange Commission. The filing identifies David Paul Keenan as the beneficial owner, who currently serves as Executive Vice President and Chief Operating Officer of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amarin Corporation plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 31, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL4gXnp1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AMRN"],"gpt_icon":0},{"id":"2579452103","title":"Amarin (AMRN) Unprofitable as Losses Worsen, Profit Growth Forecasts Test Bullish Turnaround Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2579452103","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579452103?lang=en_us&edition=fundamental","pubTime":"2025-10-31 14:30","pubTimestamp":1761892228,"startTime":"0","endTime":"0","summary":"Amarin (AMRN) remains unprofitable with losses accelerating at 30.6% per year over the past five years, while its net profit margin has shown no signs of improvement for the latest reported period. Looking ahead, analysts forecast earnings to grow sharply at 98.63% per year, with the company expected to achieve profitability within three years. This is despite revenue being projected to fall by 15.7% per year over that timeframe. Investors are parsing these results for signs that Amarin’s...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amrn/amarin/news/amarin-amrn-unprofitable-as-losses-worsen-profit-growth-fore","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-amrn/amarin/news/amarin-amrn-unprofitable-as-losses-worsen-profit-growth-fore","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","AMRN","BK4112","BLSH"],"gpt_icon":0},{"id":"2579594110","title":"Amarin Corp : Leerink Partners Raises Target Price to $12 From $10","url":"https://stock-news.laohu8.com/highlight/detail?id=2579594110","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579594110?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:11","pubTimestamp":1761822678,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nFWN3WB1OG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMRN","BK4139"],"gpt_icon":0},{"id":"2579167296","title":"Amarin Corporation’s Financial Health at Risk Amid Global Trade Uncertainties","url":"https://stock-news.laohu8.com/highlight/detail?id=2579167296","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579167296?lang=en_us&edition=fundamental","pubTime":"2025-10-30 14:02","pubTimestamp":1761804144,"startTime":"0","endTime":"0","summary":"Amarin Corporation Plc (AMRN) has disclosed a new risk, in the Capital Markets category. Amarin Corporation Plc faces significant business risks du...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amarin-corporations-financial-health-at-risk-amid-global-trade-uncertainties?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amarin-corporations-financial-health-at-risk-amid-global-trade-uncertainties?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMRN","BK4139"],"gpt_icon":0},{"id":"2579188200","title":"European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2579188200","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579188200?lang=en_us&edition=fundamental","pubTime":"2025-10-29 23:05","pubTimestamp":1761750332,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts were moving higher late Wednesday morning, rising 0.34% to 1,607.10 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP  and telecommunications company Ericsson , which climbed 16.9% and 4.1% respectively. They were followed by lender Banco Santander  and health technology company Royal Philips , which advanced 3.5% and 1.4% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies  and biotech firm Evaxion , which fell 5.3% and 5.1% respectively. They were followed by semiconductor company Sequans Communications  and software firm SAP , which were down 4% and 3.2% respectively.From the UK and Ireland, the gainers were led by pharmaceutical company GSK  and mining company BHP Group , which rose 6% and 2.3% respectively. They were followed by biotech firm Trinity Biotech  and oil and gas company Shell , which were up","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NCNA","LU0278409577.USD","BK7142","EVAX","SQNS","BK4201","LU1829250122.USD","SAN","GSK","BK4613","BK4141","BK4505","LU0320765646.SGD","BK4107","LU0098860793.USD","LU1162221912.USD","SHEL","BHP.AU","BK4020","BK7095","MREO","BK4515","BK4532","BK4521","BK4591","BK4528","LU2236285917.USD","AMRN","BK7511","ERIC","PHG","BK4168","LU0300736062.USD","BK4082","BK7507","LU0300736492.USD","AFG","DBVT","BK4554","EDAP","TRIB","BK4139","GSK.UK","SAN.AU","SAP","BHP","BK4207","BDRX","BK4117"],"gpt_icon":0},{"id":"2579297490","title":"Amarin Reports Q3 Net Revenue of $49.7 Million and Operating Loss of $11.1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2579297490","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579297490?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:02","pubTimestamp":1761735737,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amarin Corporation plc published the original content used to generate this news brief via GlobeNewswire  on October 29, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nNDL5V5zpc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU2210150020.SGD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4588","AMRN","NDAQ","IE00BKPKM429.USD","BK4585","LU2210149790.SGD","BK4112","LU2095319765.USD","IE00BGHQF748.EUR","LU0314104364.USD"],"gpt_icon":0},{"id":"2579797413","title":"Amarin Corp: in Q3 2025, Co Recognized $9.4 Mln in Restructuring Charges Related to Implementation of the Global Restructuring Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2579797413","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579797413?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:00","pubTimestamp":1761735606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA7FHM8H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMRN","BK4139"],"gpt_icon":0},{"id":"2579154974","title":"Amarin Corp: Targeting Sustainable Positive Free Cash Flow in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2579154974","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579154974?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:00","pubTimestamp":1761735606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nTUA7FHM8H:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AMRN","BK4139"],"gpt_icon":0},{"id":"2579097719","title":"Amarin Reports Third Quarter 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2579097719","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579097719?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:00","pubTimestamp":1761735600,"startTime":"0","endTime":"0","summary":"Company completes transition to fully partnered commercialization model across all international markets Q3 2025 performance reflects initial impact of new approach to Europe, ongoing expansion of Res","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/29/3176292/18362/en/Amarin-Reports-Third-Quarter-2025-Financial-Results.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRN","IPE","BK4139","BK4153","TG","BK4090"],"gpt_icon":0},{"id":"2579973786","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2579973786","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579973786?lang=en_us&edition=fundamental","pubTime":"2025-10-29 18:00","pubTimestamp":1761732000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·AerCap Hldgs NV                                   3Q      3.10    7:00 AM. ·American Elec Pwr                                 3Q      1.81    6:57 AM. ·Amer. Hms 4 Rent                                  3Q       .19        AMC","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GOOGL","AMSC","GOOG","BELFB","CBZ","BBD","GT","EBAY","ALSN","AROC","BIO.B","CALX","BNL","AVB","BELFA","CAT","AVTR","ADP","CVNA","AMSF","BRY","COHU","BHC","BA","AWK","AEM","AR","ACRE","AXGN","AMRN","BBIO","BIO","AXS","BLCO","BLKB","AMH","ATRC","ADAM","BOOT","ALGN","BXMT","AEP","AVT","CRSP","AGI","AER","AVNW","BSBR","ETSY","AM"],"gpt_icon":1},{"id":"2578264960","title":"Amarin Corporation PLC  expected to post a loss of 57 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2578264960","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578264960?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:45","pubTimestamp":1761569118,"startTime":"0","endTime":"0","summary":"Amarin Corporation PLC  expected to post a loss of57cents a share - Earnings Preview Amarin Corporation PLC AMRN.OQ AMRN.O is expected to  show a rise in quarterly revenue when it reports  results on ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nL8N3W8101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMRN","BK4139"],"gpt_icon":0},{"id":"2578645275","title":"Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=2578645275","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578645275?lang=en_us&edition=fundamental","pubTime":"2025-10-27 20:00","pubTimestamp":1761566400,"startTime":"0","endTime":"0","summary":"DUBLIN and BRIDGEWATER, N.J., Oct.  27, 2025  (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a company committed to advancing the science of cardiovascular care worldwide, today issued the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/27/3174541/18362/en/Amarin-Issues-Statement-Supporting-FDA-s-Action-to-Revise-Labeling-for-Fenofibrate-Drugs-Reinforcing-a-Lack-of-Cardiovascular-Benefit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4153","TG","BK4082","CSII","AMRN","WAC","CV","IPE","BK4090"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amarincorp.com","stockEarnings":[{"period":"1week","weight":-0.1318},{"period":"1month","weight":-0.1141},{"period":"3month","weight":-0.0433},{"period":"6month","weight":0.0838},{"period":"1year","weight":0.5602},{"period":"ytd","weight":0.4804}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.123571},{"month":2,"riseRate":0.28125,"avgChangeRate":-0.049931},{"month":3,"riseRate":0.46875,"avgChangeRate":0.001415},{"month":4,"riseRate":0.4375,"avgChangeRate":0.060083},{"month":5,"riseRate":0.363636,"avgChangeRate":-0.012581},{"month":6,"riseRate":0.484848,"avgChangeRate":0.002623},{"month":7,"riseRate":0.25,"avgChangeRate":-0.030175},{"month":8,"riseRate":0.5625,"avgChangeRate":0.06306},{"month":9,"riseRate":0.4375,"avgChangeRate":0.077692},{"month":10,"riseRate":0.375,"avgChangeRate":-0.048639},{"month":11,"riseRate":0.5625,"avgChangeRate":0.109863},{"month":12,"riseRate":0.4375,"avgChangeRate":-0.022357}],"exchange":"NASDAQ","name":"Amarin Corp PLC","nameEN":"Amarin Corp PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Amarin Corp PLC(AMRN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Amarin Corp PLC(AMRN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Amarin Corp PLC,AMRN,Amarin Corp PLC股票,Amarin Corp PLC股票老虎,Amarin Corp PLC股票老虎国际,Amarin Corp PLC行情,Amarin Corp PLC股票行情,Amarin Corp PLC股价,Amarin Corp PLC股市,Amarin Corp PLC股票价格,Amarin Corp PLC股票交易,Amarin Corp PLC股票购买,Amarin Corp PLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Amarin Corp PLC(AMRN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Amarin Corp PLC(AMRN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction